Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Prolymphocytic × Positron-Emission Tomography × Clear all

Sponsor

Conditions

Prostatic Neoplasms 6 Lymphoma, Non-Hodgkin 3 Neoplasms 2 Neoplasm Metastasis 2 Lymphoma 2 Disease 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Vasculitis 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Papillomavirus Infections 1 Osteomyelitis 1 Nose Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Pulmonary Nodules 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia 1

Interventions

fludarabine phosphate 20 Mycophenolic Acid 15 Whole-Body Irradiation 14 Peripheral Blood Stem Cell Transplantation 11 Cyclophosphamide 11 Cyclosporine 10 Cyclosporins 8 fludarabine 7 Tacrolimus 7 Rituximab 7 Antilymphocyte Serum 7 Busulfan 6 Sirolimus 4 Melphalan 4 Methotrexate 3 Cytarabine 3 Cord Blood Stem Cell Transplantation 3 pegfilgrastim 2 ibrutinib 2 Thiotepa 2 Oxaliplatin 2 Filgrastim 2 Etoposide 2 Darbepoetin alfa 2 thymoglobulin 1 selinexor 1 ofatumumab 1 immunotoxin HA22 1 ferrous sulfate 1 ferric gluconate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡